A 61-year-old man presented with central lymphocytic hypophysitis. Initial pituitary MRI imaging was normal, except for loss of the "bright spot" of the posterior lobe. A diagnosis of idiopathic diabetes insipidus was made. Two years later, pituitary gland enlargement with panhypopituitarism was detected. Eight months after commencing a replacement dose of corticosteroid, the pituitary enlargement was reduced in size. These findings resulted in a diagnosis of lymphocytic hypophysitis. In patients with idiopathic diabetes insipidus, it is important to suspect lymphocytic hypophysitis and to perform a long follow-up to repeat endocrinological examinations and pituitary imaging.
Introduction
Lymphocytic hypophysitis is an uncommon autoimmune disease in which the pituitary gland is enlarged secondary to inflammatory infiltration with lymphocytes, plasma cells and macrophages, and atrophic due to destruction of pituitary tissue and replacement by fibrosis (1) . Lymphocytic hypophysitis occurs mainly in women and often presents in the later stages of pregnancy (2) . Many patients present with headaches or visual field impairment due to extrasellar pituitary enlargement and impaired secretion of one or more pituitary hormones presenting with varying degrees of pituitary dysfunction (3) . Lymphocytic hypophysitis is considered a syndrome including disorders of the anterior pituitary (lymphocytic adenohypophysitis), and the posterior pituitary (lymphocytic infundibuloneurohypophysitis). The latter usually presents with central diabetes insipidus (4) . Although central diabetes insipidus may be idiopathic or secondary to a disturbance of the hypothalamic-neurohypophysial system including trauma, infection, tumors or other lesions, lymphocytic infundibuloneurohypophysitis has been suggested as the underlying cause in some cases previously labeled "idiopathic diabetes insipidus" (5) . Lymphocytic hypophysitis has been recently recognized as a cause of hypopituitarism, although its precise incidence remains unclear. Here, we report an unusual case of a 61-year-old man with lymphocytic hypophysitis, who developed enlargement of pituitary gland and thickening of pituitary stalk 2 years after onset of central diabetes insipidus. (Fig. 1) . Neurohypophyseal function was evaluated by 5% hypertonic saline infusion test ( Fig. 2A) . During the load of hypertonic saline, the urinary osmolality remained between 75 and 215 mmol/kg, and the plasma arginine vasopressin (AVP) was not increased. After desmopressin acetate (DDAVP) loading test, the urinary osmolality rose from 76 to 235 mmol/kg (Fig. 2B ). Basal concentrations of ACTH, TSH, PRL, FSH, and LH were normal, and there were normal responses to appropriate stimuli, except for a decreased response of PRL and GH (Fig. 3) . A diagnosis of central diabetes insipidus was made based on these tests. We found no evidence of the origins of central diabetes insipidus, Based on the clinical data and MRI findings, we made a diagnosis of idiopathic diabetes insipidus. The patient was prescribed intranasal desmopressin at a dose of 10 μg/day, and the polyuria and polydipsia were well controlled. MRI of the pituitary gland with gadolinium contrast was repeated 18 months later in September 2008. Slight thickening of the pituitary stalk was observed (Fig. 4a ). Basal concentrations of the pituitary anterior hormones, such as ACTH, TSH, PRL, FSH, LH, and GH, were normal. On MRI 4 months later, the thickening of the pituitary stalk was increased, and showed homogeneous enhancement (Fig. 4b) . In March 2009, he was admitted to our hospital with onset of low-grade fever, night sweats, general malaise, anorexia, and oliguria. MRI with gadolinium contrast revealed symmetrical enlargement of the pituitary gland with homogeneous enhancement, that did not abut the optic chiasm (Fig. 4c ). Visual field examination was normal. On laboratory examination, urinary excretion of sodium was elevated despite a low serum sodium level. Basal concentrations of plasma ACTH, cortisol, LH, FSH and TSH were low, while PRL was elevated ( Table 2 ). The results of pituitary stimulation tests are shown in Fig. 5 . The response of ACTH to CRH, GH to GRH, and LH and FSH to GnRH were blunted. Oral administration of 15 mg/day hydrocortisone was started as replacement therapy for hypoadrenocortism. Immediately after the replacement therapy, he was well and had no symptoms suggestive of glucocorticoid deficiency. The replacement therapy with L-thyroxine or recombinant human growth hormone was not initiated. We next investigated the origins of pituitary gland enlargement in this case. The level of serum angiotensin-converting enzyme (ACE) and the tumor markers α-fetoprotein (AFP) and human chorionic gonadotropin (hCG)-β were not increased, and antinuclear antibodies (ANA), proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA), and myeloperoxidaseantineutrophil cytoplasmic antibodies (MPO-ANCA) were negative ( Table 2) . Results of chest x ray were normal. Therefore, pituitary nodular lesions, including sarcoidosis, tuberculosis, and granulomatous hypophysitis, were excluded. The patient refused pituitary biopsy, and selected watchful waiting to observe the clinical course of the pituitary mass. Clinical examination and MRI findings were compatible with a diagnosis of lymphocytic hypophysitis, including anterior hypophysitis and infundibulo- neurohypophysitis. Anti-pituitary antibody was also negative. He was discharged from our hospital on the 25th day after admission under the replacement therapy of 10 μg/day intranasal desmopressin and 15 mg/day hydrocortisone. Follow-up MRI examination 8 months later showed that the pituitary and stalk had reduced in size (Fig. 4d) . However, anterior and posterior pituitary dysfunction failed to improve.
T a b l e 1 . L a b o r a t o r y Da t a o n Ad mi s s i o n

( A) S a g i t t a l T 1 -we i g h t e d i ma g e wi t h o u t g a d o l i ni u m c o n t r a s t . L o s s o f t h e " b r i g h t s p o t " o f t h e p o s t e r i o r p i t u i t a r y g l a n d wa s o b s e r v e d . ( B ) Co r o n a l T 1 -we i g h t e d i ma g e wi t h o u t g a d o l i n i u m c o n t r a s t . ( C) S a g i t t a l T 1 -we i g h t e d i ma g e wi t h g a d o l i n i u m c o n t r a s t . T h e r e wa s n o ma s s i n t h e p i t u i t a r y g l a n d . ( D) Co r o n a l T 1 -we i g h t e d i ma g e wi t h g a d o l i ni u m c o n t r a s t .
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Discussion
Lymphocytic hypophysitis is an autoimmune disease char- T a b l e 2 . E n d o c r i n o l o g i c a l a n d Au t o i mmu n o l o g i c a l Da t a o n E n l a r g e me n t acterized by lymphocytic infiltration and destruction of the pituitary gland. Its autoimmune pathogenesis was supported by the presence of circulating anti-pituitary antibodies in some patients (2, 6) . However, these antibodies cannot always be positive markers for lymphocytic hypophysitis because they are nonspecific and low titer. The present patient was negative for these antibodies. In 30% of cases, lymphocytic hypophysitis coexists with other autoimmune disorders, including chronic thyroiditis, Graves' disease, retroperitoneal fibrosis, and idiopathic adrenalitis (7). There have been few reports regarding the clinical course of lymphocytic hypophysitis. Typically, this disease occurs in young women in late pregnancy or in the postpartum period (2). However, there have been some recent reports of men presenting with lymphocytic hypophysitis (8) (9) (10) . Previously, distinctions were made between lymphocytic hypophysitis and lymphocytic infundibulohypophysitis. There have been some recent reports of patients presenting with both anterior and poste-rior pituitary dysfunction (2, 7). Therefore, it may be appropriate to consider lymphocytic hypophysitis as a syndrome involving both the anterior and posterior pituitary (4) . Differential diagnosis to differentiate lymphocytic hypophysitis from other pituitary diseases includes pituitary adenoma, sarcoidosis, tuberculosis, and granulomatous hypophysitis. It is not always easy to exclude these diseases by the diagnostic methods, including laboratory findings (ACE, AFP, hCG-β, and ANCA), chest x ray films and MRI findings. MRI studies are useful for the differential diagnosis of lymphocytic hypophysitis, indicating that marked and homogeneous contrast enhancement of the pituitary gland is unique for lymphocytic hypophysitis. The rapid regression of the pituitary mass by high-dose steroid therapy may help confirm the diagnosis of lymphocytic hypophysitis (11, 12) . Lymphocytic hypophysitis is usually diagnosed by pituitary biopsy. In the present patient, pituitary biopsy was not performed, because he wished to avoid an invasive test. He agreed to undergo pituitary biopsy if the pituitary mass showed further expansion or visual disturbance by the mass was noted. In fact, he experienced regression of the pituitary mass 8 months after commencement of a replacement dose of corticosteroid (0.3 mg/body weight/day hydrocortisone). Therefore, a diagnosis of lymphocytic hypophysitis can be made based on the clinical course and MRI findings.
F i g u r e 3 . Re s p o n s e o f p i t u i t a r y h o r mo n e s t o i n t r a v e n o u s i n j e c t i o n o f CRH ( 1 0 0 μ g ) , GRH ( 1 0 0 μ g ) , T RH ( 5 0 0 μ g ) , a n d L H-RH ( 1 0 0 μ g ) o n o n s e t o f c e n t r a l d i a b e t e s i n s i p i d u s .
F i g u r e 4 . T i me c o u r s e o f MRI f i n d i n g s a f t e r ma n i f e s t a t i o n o f d i s e a s e ( Up p e r c o l u mn : S a g i t t a l T 1 -we i g h t e d i ma g e wi t h o u t g a d o l i n i u m c o n t r a s t . Mi d d l e c o l u mn : Co r o n a l T 1 -we i g h t e d i ma g e wi t h o u t g a d o l i n i u m c o n t r a s t . B o t t o m c o l u mn : S a g i t t a l T 1 -we i g h t e d i ma g e wi t h g a d o l i n i u m c o n t r a s t . ) . ( a ) E i g h t e e n mo n t h s a f t e r o n s e t o f c e n t r a l d i a b e t e s i n s i p i d u s ( S e p t e mb e r 2 0 0 8 ) . ( b ) T we n t y -t wo mo n t h s a f t e r o n s e t ( J a n u a r y 2 0 0 9 ) . ( c ) T wo y e a r s a f t e r o n s e t ( Ma r c h 2 0 0 9 ) . ( d ) E i g h t mo n t h s a f t e r d i s c h a r g e ( No v e mb e r 2 0 0 9 ) .
F i g u r e 5 . Re s p o n s e o f p i t u i t a r y h o r mo n e s t o i n t r a v e n o u s i n j e c t i o n o f CRH ( 1 0 0 μ g ) , GRH ( 1 0 0 μ g ) , T RH ( 5 0 0 μ g ) , a n d L H-RH ( 1 0 0 μ g ) o n e n l a r g e me n t o f t h e p i t u i t a r y g l a n d a n d t h i c k e n i n g o f t h e p i t u i t a r y s t a l k .
o f t h e P i t u i t a r y Gl a n d
In lymphocytic hypophysitis, there is evidence of hypopituitarism. Lymphocytic hypophysitis often results in isolated ACTH deficiency, combined ACTH/TSH deficiencies, or multiple pituitary hormone deficiency (generally in descending order of frequency ACTH > TSH > FSH/LH > GH > PRL). Our patient presented panhypopituitarism, in particular ACTH complete deficiency, 2 years after the onset of central diabetes insipidus. Oliguria and hyponatremia were observed, followed by the addition of hypoadrenocortism to diabetes insipidus, i.e., "masked diabetes insipidus". Glucocorticoid is known to attenuate the action of vasopressin in the renal collecting tubules (13) . Glucocorticoid deficiency could cause hyponatremia due to the decrease of water diuresis as well as the increase of Na excretion. It has been reported that glucocorticoid deficiency due to anterior hypophysitis could enhance vasopressin synthesis in the hypothalamus, and that vasopressin could upregulate expression of aquaporin-2 gene in the kidney, exaggerating the antidiuretic action of vasopressin, in rats (14, 15) .
A unique and unusual aspect of the present case is the long latent period between onset of central diabetes insipidus and development of enlargement of the pituitary gland and thickening of the pituitary stalk. In patients presenting lymphocytic hypophysitis with hypopituitarism, enlargement of the pituitary gland or thickening of the pituitary stalk can usually be seen on pituitary MRI. There have been reports of a few cases of lymphocytic hypophysitis presenting with pituitary dysfunction with normal initial pituitary imaging results (8, 16, 17) . The mechanism responsible for such a long latent period is not known. It is likely that there were already inflammatory changes in hypophysis, although swelling of the pituitary gland was not clearly identified on MRI. Pituitary dysfunction with no pituitary abnormalities on MRI is often labeled as idiopathic hypopituitarism. In our patient, a diagnosis of idiopathic diabetes insipidus was made, because the initial MRI detected only loss of "bright spot" as a signal of the posterior pituitary gland, and not enlargement of the pituitary gland or thickening of the pituitary stalk. We suggest that in patients with idiopathic diabetes insipidus, it is important to suspect a diagnosis of lymphocytic hypophysitis and serially perform endocrinological examinations and pituitary imaging to detect early hypopituitarism or enlargement of the pituitary gland.
